According to the latest data from the Hong Kong Stock Exchange, on May 12, Schroders PLC increased its holding in HENGRUI PHARMA (01276) by 663,000 shares. The transaction was executed at a price of HK$68.7041 per share, amounting to a total consideration of approximately HK$45.5508 million. Following this acquisition, Schroders PLC's total shareholding in the company has risen to 13.1712 million shares, representing a 5.1% stake.